机构:[1]School of Medicine, University of Electronic Science and Technology of China, Chengdu, People’s Republic of China四川省人民医院[2]Department of Gynecologic Oncology, Sichuan Cancer Hospital & Institute, The Affiliated Cancer Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu, People’s Republic of China四川省人民医院四川省肿瘤医院
Introduction: Cervical cancer is the fourth most common malignancy in women worldwide, and sinonasal inverted papilloma (SIP) is a rare benign sinus tumor with characteristics including a destructive growth pattern, high recurrence rate, and common malignant transformation. Cervical squamous cell carcinoma (SCC) combined with SIP has not been reported thus far.Case Presentation: A 55-year-old woman was diagnosed with cervical SCC in our center and treated with concurrent radio-chemotherapy. During the follow-up period after the completion of cervical cancer treatment, the progression of cervical squamous cell carcinoma was first considered because the squamous cell carcinoma antigen (SCCA) levels remained high and slowly increased. However, SIP was found after a detailed investigation. The SCCA levels returned to normal after surgery. Two months after the surgery, because SCCA slowly increased again, it was found that the SIP recurred. After additional surgical treatment, the SCCA level returned to normal.Discussion and Conclusion: First, SCCA is an important indicator for monitoring changes in cervical SCC. When the changes in SCCA levels are inconsistent with the prognosis of cervical SCC, we should be vigilant about considering the possibility of other diseases existing at other sites in the body, which might lead to the earlier detection and treatment of SIP. Second, We recommended that SCCA be used as a routine monitoring index for SIP. If available, SCCA1 and SCCA2 should be evaluated to provide a more detailed assessment. Finally, for a high recurrence rate of SIP, anti-HPV treatment might be considered to reduce the risk of recurrence.
第一作者机构:[1]School of Medicine, University of Electronic Science and Technology of China, Chengdu, People’s Republic of China
通讯作者:
通讯机构:[2]Department of Gynecologic Oncology, Sichuan Cancer Hospital & Institute, The Affiliated Cancer Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu, People’s Republic of China[*1]Department of Gynecologic Oncology, Sichuan Cancer Hospital & Institute, The Affiliated Cancer Hospital, School of Medicine, University of Electronic Science and Technology of China, No. 55, Section 4, South Renmin Road, Chengdu, 610041, People’s Republic of China
推荐引用方式(GB/T 7714):
Hou Xiao Yu,Peng Chun Rong,Zhang Guo Nan,et al.A Rare Case of Cervical Squamous Cell Carcinoma Concurrent with Sinonasal Inverted A Case[J].INTERNATIONAL JOURNAL OF WOMENS HEALTH.2022,14:1657-1666.doi:10.2147/IJWH.S380385.
APA:
Hou, Xiao Yu,Peng, Chun Rong,Zhang, Guo Nan&Wang, Deng Feng.(2022).A Rare Case of Cervical Squamous Cell Carcinoma Concurrent with Sinonasal Inverted A Case.INTERNATIONAL JOURNAL OF WOMENS HEALTH,14,
MLA:
Hou, Xiao Yu,et al."A Rare Case of Cervical Squamous Cell Carcinoma Concurrent with Sinonasal Inverted A Case".INTERNATIONAL JOURNAL OF WOMENS HEALTH 14.(2022):1657-1666